2019 update of the drug resistance mutations in HIV-1

Abstract

The 2019 edition of the IAS-USA drug resistance mutations list updates the Figure last published in January 2017. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.

Figures

Figure 1.

Display of the Figure Bar: Amino acid position, wild type, mutation conferring resistance, and indication of insertion mutation.